BioLogic Company Company Profile

05:14 EDT 23rd March 2018 | BioPortfolio

BioLogic grows, formulates, and sells, natural insect parasites and pathogens of pests. Our natural biocontrol products for horticulture, home, lawn, garden, and greenhouse kill insect pests, but are more specific and therefore safer than many other controls. As safe pesticides, they can be allowed to persist longer than many chemicals. With their modes of action, there is less risk for pest insect populations to develop resistance.
This site will help you decide if our natural pesticide controls (beneficial nematodes, ladybugs, praying mantises, etc.) can help you and expedite ordering, shipment, and quick delivery. It also serves as a brief reference about BioLogic Company


P.O. Box 177
Willow Hill
United States of America


Phone: (717)349-2789

News Articles [193 Associated News Articles listed on BioPortfolio]

Bio Rad BioLogic LP Controller (11839)

$0.99 (0 Bids)End Date: Sunday Feb-4-2018 18:03:36 PSTBid now | Add to watch list Biotech365 : Bio Rad BioLogic LP Controller (11839) BioMarketplace You want to propose your products or a Biotech...

Developing our own biologic drugs

The increase in the burden of chronic diseases globally has called for greater measures in ensuring safe and effective patient treatment. Biologic drugs, or biologic response modifiers, are a branch o...

TaiMed's innovative biologic for HIV gets FDA nod

A new approval signals a shift to China-based manufacturing for biologic drugs, potentially opening the door for more. 

Chinese drugmakers tap GE tech, seeing biologic boom ahead

Zhejiang-based Clover BioPharmaceuticals is the latest to install GE Healthcare's "FlexFactory," aiming to ramp up GMP production of biologic medicines.

Biologic Use in Pregnancy Does Not Increase Infant Infection Risk

New evidence is reassuring for women with rheumatoid arthritis who need treatment with a biologic throughout pregnancy.

RA is Costly, Especially When Biologic DMARDs Are Used (CME/CE)

(MedPage Today) -- But biologic DMARDs themselves are not responsible for increased costs

Serious infection rate is low in people with rheumatoid arthritis treated with biologic DMARDs and denosumab

People with rheumatoid arthritis who take biologic disease-modifying antirheumatic drugs (DMARDs), including those who also take denosumab to avoid bone loss, have a low occurrence of infections, expe...

Maternal biologic use did not increase risk for opportunistic infections in newborns

SAN DIEGO — The use of biologic therapy for rheumatoid arthritis during pregnancy did not significantly increase risk for developing serious or opportunistic infections among infants, according to f...

PubMed Articles [183 Associated PubMed Articles listed on BioPortfolio]

Risk of Serious Infection in Patients with Psoriasis on Biologic Therapies: a Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Serious infection is a concern for patients with psoriasis on biologic therapies. We assessed the risk of serious infections of biologics used to treat psoriasis by comparison with a cohort on non-bio...

An Ethnographic Observational Study of the Biologic Initiation Conversation Between Rheumatologists and Biologic-naïve Rheumatoid Arthritis Patients.

This ethnographic market research study investigated the biologic initiation conversation between rheumatologists and biologic-naïve patients with rheumatoid arthritis to assess how therapy options, ...

Rate of serious infection in patients who are prescribed systemic biologic or nonbiologic agents for psoriasis: A large, single center, retrospective, observational cohort study.

Systemic biologic and nonbiologic agents used to treat psoriasis may or may not contribute to serious infection (SI) risk. Safety data, particularly for biologic agents, and associated risk for SI, ar...

Mechanical or Biologic Prostheses for Aortic-Valve and Mitral-Valve Replacement.

In patients undergoing aortic-valve or mitral-valve replacement, either a mechanical or biologic prosthesis is used. Biologic prostheses have been increasingly favored despite limited evidence support...

Biomarker-guided stratification of autoimmune patients for biologic therapy.

Autoimmunity results from an intersection of genetic and environmental factors that cause patient-specific perturbations in immune homeostasis. Defining autoimmunity-associated genetic factors has led...

Clinical Trials [513 Associated Clinical Trials listed on BioPortfolio]

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)

This study is designed to analyze the frequency and incidence rate of pulmonary complications in JIA participants who received biological DMARDs and non-biologic DMARDs. The participants h...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy

That anti-TNF therapy and rituximab therapy are equally effective in treating patients with rheumatoid arthritis who meet the eligibility criteria for biologic therapy in the British Socie...

Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction

To date, there have been no prospective randomized controlled trials that compare various biologic mesh materials in the context of abdominal wall reconstruction. As a result, this proposa...

Companies [1503 Associated Companies listed on BioPortfolio]

China Biologic Products, Inc.

China Biologic Products, Inc. (the "Company"), through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd, and...

BioLogic Company

BioLogic grows, formulates, and sells, natural insect parasites and pathogens of pests. Our natural biocontrol products for horticulture, home, lawn, garden, and greenhouse kill insect pests, but are ...

Nanotherapeutics, Inc.

Nanotherapeutics, Inc. is a privately held biopharmaceutical company. Its product pipeline includes, an FDA-approved injectable biologic product (OrigenTM DBM, marketing partner O...

Osteotech, Inc.

Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global leader in providing biologic solutions for regenerative medicine to support surgeons and their patients in the repair of the muscul...

Biologic GmbH & Co KG

Biologic beschäftigt sich mit der Entwicklung von biotechnologischen Produkten und Verfahren für den Umweltschutz bis zur technischen Marktreife mit entsprechendem Marketingkonzept. Nach erwiesener ...

More Information about "BioLogic Company" on BioPortfolio

We have published hundreds of BioLogic Company news stories on BioPortfolio along with dozens of BioLogic Company Clinical Trials and PubMed Articles about BioLogic Company for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioLogic Company Companies in our database. You can also find out about relevant BioLogic Company Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record